| D00136 |
Haloperidol (JP18/USP/INN); Haldol (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00140 |
Erythromycin (JP18/USP/INN); Akne-mycin (TN); Eryc (TN); Erygel (TN); Pce (TN); Staticin (TN); T-stat (TN) |
(P) unclassified |
| D00222 |
Acyclovir (USP); Aciclovir (JP18/INN); Sitavig (TN); Zovirax (TN) |
(P) unclassified |
| D00225 |
Alprazolam (JP18/USP/INN); Xanax (TN) |
(P) unclassified |
| D00228 |
Amoxapine (JP18/USP/INN); Asendin (TN) |
(P) CYP inhibition: CYP2D6 |
| D00246 |
Budesonide (JP18/USP/INN); Entocort EC (TN); Pulmicort (TN); Rhinocort (TN); Uceris (TN) |
(P) CYP inhibition: CYP3A4 |
| D00252 |
Carbamazepine (JP18/USP/INN); Equetro (TN); Tegretol (TN) |
(P) CYP inhibition: CYP3A4 |
| D00255 |
Carvedilol (JP18/USP/INN); Artist (TN); Coreg (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00283 |
Clozapine (JAN/USP/INN); Clozaril (TN) |
(P) CYP inhibition: CYP3A4 |
| D00293 |
Diazepam (JP18/USP/INN); Diastat (TN); Valium (TN) |
(P) CYP inhibition: CYP3A4 |
| D00298 |
Digoxin (JP18/USP); Lanoxicaps (TN); Lanoxin (TN) |
(P) unclassified |
| D00319 |
Felodipine (JP18/USP/INN); Plendil (TN) |
(P) CYP inhibition: CYP3A4 |
| D00320 |
Fentanyl (JAN/USP/INN); Duragesic (TN); Subsys (TN) |
(P) CYP inhibition: CYP3A4 |
| D00350 |
Itraconazole (JP18/USP); Itrizole (TN); Sporanox (TN) |
(P) CYP inhibition: CYP3A4 |
| D00364 |
Loratadine (JAN/USP/INN); Claritin (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00368 |
Mebendazole (JAN/USP/INN); Vermox (TN) |
(P) unclassified |
| D00371 |
Theophylline (JP18); Elixophyllin (TN); Quibron-t (TN); Theo-24 (TN); Theodur G (TN); Theolair (TN); Uniphyl (TN) |
(P) unclassified |
| D00387 |
Triazolam (JP18/USP/INN); Halcion (TN) |
(P) CYP inhibition: CYP3A4 |
| D00398 |
Valacyclovir hydrochloride (USP); Valaciclovir hydrochloride (JP18); Valtrex (TN) |
(P) unclassified |
| D00415 |
Zolmitriptan (JAN/USP/INN); Zomig (TN) |
(P) unclassified |
| D00426 |
Risperidone (JP18/USP/INN); Risperdal (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00435 |
Nevirapine (JAN/USP/INN); Viramune (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00437 |
Nifedipine (JP18/USP/INN); Adalat (TN); Afeditab CR (TN); Procardia (TN) |
(P) CYP inhibition: CYP3A4 |
| D00457 |
Quazepam (JAN/USP/INN); Doral (TN) |
(P) CYP inhibition: CYP3A4 |
| D00458 |
Quetiapine fumarate (JP18/USP); Seroquel (TN) |
(P) CYP inhibition: CYP3A4 |
| D00471 |
Praziquantel (JAN/USP/INN); Biltricide (TN) |
(P) CYP inhibition: CYP3A4 |
| D00472 |
Prednisolone (JP18/USP/INN); Delta-cortef (TN) |
(P) unclassified |
| D00477 |
Procainamide hydrochloride (JP18/USP); Procan SR (TN); Procanbid (TN); Pronestyl (TN) |
(P) unclassified |
| D00483 |
Propranolol hydrochloride (JP18/USP); Inderal (TN); Innopran XL (TN) |
(P) CYP inhibition: CYP2D6 |
| D00512 |
Phenytoin (JP18/USP/INN); Dilantin (TN) |
(P) unclassified |
| D00528 |
Caffeine (USP); Anhydrous caffeine (JP18); Anhydrous caffeine (TN); Respia (TN) |
(P) unclassified |
| D00531 |
Nitrazepam (JP18/USAN/INN); Benzalin (TN); Nitrazepam (TN) |
(P) unclassified |
| D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) CYP inhibition: CYP3A4 |
| D00559 |
Pramipexole dihydrochloride (USP); Pramipexole hydrochloride hydrate (JAN); Pramipexole dihydrochloride monohydrate; Mirapex (TN) |
(P) unclassified |
| D00563 |
Mirtazapine (JAN/USP/INN); Remeron (TN); Reflex (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00570 |
Colchicine (JP18/USP); Colchicine (TN) |
(P) CYP inhibition: CYP3A4 |
| D00600 |
Labetalol hydrochloride (JP18/USP); Normodyne (TN); Trandate (TN) |
(P) unclassified |
| D00601 |
Metoprolol tartrate (JP18/USP); Lopressor (TN) |
(P) CYP inhibition: CYP2D6 |
| D00603 |
Timolol maleate (JP18/USP); Blocadren (TN); Istalol (TN); Timoptic (TN) |
(P) CYP inhibition: CYP2D6 |
| D00606 |
Guanfacine hydrochloride (JAN/USP); Intuniv (TN); Tenex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00615 |
Amlodipine besylate (USP); Amlodipine besilate (JP18); Norvasc (TN) |
(P) CYP inhibition: CYP3A4 |
| D00616 |
Diltiazem hydrochloride (JP18/USP); Cardizem (TN); Cartia XT (TN); Dilacor XR (TN); Dilt-CD (TN) |
(P) CYP inhibition: CYP3A4 |
| D00617 |
Nicardipine hydrochloride (JP18/USAN); Cardene (TN) |
(P) CYP inhibition: CYP3A4 |
| D00619 |
Verapamil hydrochloride (JP18/USP); Calan (TN); Covera-hs (TN); Vasolan (TN); Verelan (TN) |
(P) CYP inhibition: CYP3A4 |
| D00629 |
Nitrendipine (JP18/USAN/INN); Baypress (TN) |
(P) CYP inhibition: CYP3A4 |
| D00638 |
Flecainide acetate (JP18/USP); Tambocor (TN) |
(P) CYP inhibition: CYP2D6 |
| D00639 |
Mexiletine hydrochloride (JP18/USP); Mexitil (TN) |
(P) CYP inhibition: CYP2D6 |
| D00661 |
Cevimeline hydrochloride (USAN); Cevimeline hydrochloride hydrate (JAN); Evoxac (TN); Saligren (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00670 |
Donepezil hydrochloride (JP18/USP); Aricept (TN) |
(P) CYP inhibition: CYP3A4 |
| D00672 |
Hydroxyzine hydrochloride (JP18/USP); Hydroxyzine dihydrochloride; Atarax (TN); Vistaril (TN) |
(P) unclassified |
| D00680 |
Methylergonovine maleate (USP); Methylergometrine maleate (JP18); Methergine (TN) |
(P) CYP inhibition: CYP3A4 |
| D00687 |
Salmeterol xinafoate (JAN/USP); Serevent (TN) |
(P) CYP inhibition: CYP3A4 |
| D00690 |
Mometasone furoate (JAN/USP); Asmanex (TN); Elocon (TN) |
(P) CYP inhibition: CYP3A4 |
| D00710 |
Valproate sodium (USAN); Sodium valproate (JP18); Depakene (TN); Selenica (TN) |
(P) unclassified |
| D00722 |
Oxybutynin chloride (USP); Oxybutynin hydrochloride (JP18); Ditropan (TN); Gelnique (TN) |
(P) CYP inhibition: CYP3A4 |
| D00753 |
Sirolimus (JAN/USAN/INN); Rapamune (TN); Rapamycin (TN) |
(P) CYP inhibition: CYP3A4 |
| D00765 |
Rocuronium bromide (JAN/USP/INN); Zemuron (TN) |
(P) unclassified |
| D00776 |
Tizanidine hydrochloride (JP18/USP); Zanaflex (TN) |
(P) unclassified |
| D00785 |
Selegiline hydrochloride (JAN/USP); Eldepryl (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00809 |
Amitriptyline hydrochloride (JP18/USP); Elavil (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00811 |
Clomipramine hydrochloride (JP18/USP); Anafranil (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00815 |
Imipramine hydrochloride (JP18/USP); Tofranil (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00818 |
Maprotiline hydrochloride (JP18/USP); Ludiomil (TN) |
(P) CYP inhibition: CYP2D6 |
| D00820 |
Trazodone hydrochloride (JAN/USP); Desyrel (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00821 |
Venlafaxine hydrochloride (JAN/USP); Effexor (TN) |
(P) CYP inhibition: CYP2D6 |
| D00825 |
Sertraline hydrochloride (JAN/USP); Zoloft (TN) |
(P) CYP inhibition: CYP3A4 |
| D00831 |
Mefloquine hydrochloride (JP18/USP); Lariam (TN) |
(P) unclassified |
| D00836 |
Buprenorphine hydrochloride (JP18/USP); Buprenex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00848 |
Dextromethorphan hydrobromide (USP); Dextromethorphan hydrobromide hydrate (JP18); Benylin DM (TN) |
(P) CYP inhibition: CYP2D6 |
| D00892 |
Fluvastatin sodium (JAN/USP); Lescol (TN) |
(P) CYP inhibition: CYP3A4 |
| D00944 |
Metformin hydrochloride (JP18/USP); Glucophage (TN) |
(P) unclassified |
| D00964 |
Letrozole (JAN/USP/INN); Femara (TN) |
(P) CYP inhibition: CYP3A4 |
| D01061 |
Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP18); Irinotecan hydrochloride trihydrate; CPT 11; CPT-11; Campto (TN); Camptosar (TN); Onivyde (TN) |
(P) unclassified |
| D01096 |
Hydroxyzine pamoate (JP18/USP); Atarax-P (TN); Vistaril pamoate (TN) |
(P) unclassified |
| D01104 |
Barnidipine hydrochloride (JAN); Hypoca (TN) |
(P) CYP inhibition: CYP3A4 |
| D01115 |
Eplerenone (JP18/USAN/INN); Inspra (TN) |
(P) CYP inhibition: CYP3A4 |
| D01144 |
Prulifloxacin (JAN/INN); Sword (TN) |
(P) unclassified |
| D01145 |
Azelnidipine (JP18/INN); Calblock (TN) |
(P) CYP inhibition: CYP3A4 |
| D01146 |
Iguratimod (JAN/INN) |
(P) unclassified |
| D01164 |
Aripiprazole (JP18/USP/INN); Abilify (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D01167 |
Magnesium oxide (JP18/USP); Magmitt (TN) |
(P) unclassified |
| D01173 |
Cilnidipine (JP18/INN); Atelec (TN) |
(P) CYP inhibition: CYP3A4 |
| D01176 |
Blonanserin (JAN/INN); AD 5423 |
(CI,P) CYP inhibition: CYP3A4 |
| D01213 |
Tolvaptan (JP18/USAN/INN); Samsca (TN) |
(P) CYP inhibition: CYP3A4 |
| D01230 |
Flunitrazepam (JP18/USAN/INN); Rohypnol (TN) |
(P) unclassified |
| D01239 |
Prednisolone sodium succinate (JP18/USP); Kohakusanin (TN) |
(P) unclassified |
| D01245 |
Bromazepam (JP18/USAN/INN); Lectopam (TN) |
(P) unclassified |
| D01253 |
Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) |
(P) CYP inhibition: CYP3A4 |
| D01280 |
Warfarin potassium (JP18); Athrombin-K (TN) |
(P) unclassified |
| D01287 |
Levobupivacaine hydrochloride (JAN/USAN); Chirocaine (TN) |
(P) CYP inhibition: CYP3A4 |
| D01292 |
Medazepam (JP18/INN); Pamnace (TN) |
(P) unclassified |
| D01293 |
Ethyl loflazepate (JP18/INN); Meilax (TN) |
(P) CYP inhibition: CYP3A4 |
| D01361 |
Erythromycin ethylsuccinate (JP18/USP); E.E.S. (TN); Eryped (TN); Erythrocin W (TN) |
(P) unclassified |
| D01372 |
Zopiclone (JP18/INN); Amoban (TN); Zopiclone (TN) |
(P) CYP inhibition: CYP3A4 |
| D01399 |
Fentanyl citrate (JP18/USP); Abstral (TN); Fentora (TN); Lazanda (TN); Oralet (TN) |
(P) CYP inhibition: CYP3A4 |
| D01408 |
Flurazepam hydrochloride (JP18); Flurazepam monohydrochloride; Dalmate (TN) |
(P) unclassified |
| D01418 |
Tamibarotene (JAN/USAN/INN); Am 80; Amnoid (TN) |
(P) CYP inhibition: CYP3A4 |
| D01453 |
Caffeine hydrate (JP18); Caffeine monohydrate; Caffeine (TN) |
(P) unclassified |
| D01546 |
Dothiepin hydrochloride (USAN); Dosulepin hydrochloride (JAN); Dosulepin (TN) |
(P) CYP inhibition: CYP2D6 |
| D01553 |
Manidipine hydrochloride (JP18); Manidipine dihydrochloride; Calslot (TN) |
(P) CYP inhibition: CYP3A4 |
| D01604 |
Efonidipine hydrochloride ethanolate (JAN); Efonidipine hydrochloride ethanol; Efonidipine hydrochloride; NZ 105 ethanolate; Landel (TN) |
(P) unclassified |
| D01703 |
Ciclesonide (JAN/USAN/INN); Alvesco (TN); Omnaris (TN); Zetonna (TN) |
(P) CYP inhibition: CYP3A4 |
| D01708 |
Fluticasone propionate (JAN/USP); Cutivate (TN); Flonase (TN); Flovent (TN) |
(P) CYP inhibition: CYP3A4 |
| D01744 |
Brotizolam (JP18/USAN/INN); Lendormin (TN) |
(P) CYP inhibition: CYP3A4 |
| D01745 |
Domperidone (JP18/USAN/INN); Motilium (TN) |
(P) CYP inhibition: CYP3A4 |
| D01896 |
Cilostazol (JP18/USP/INN); Pletal (TN) |
(P) CYP inhibition: CYP3A4 |
| D01898 |
Haloperidol decanoate (JAN/USP); Halomonth (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D01908 |
Nilvadipine (JP18/USAN/INN); Nivadil (TN) |
(P) CYP inhibition: CYP3A4 |
| D01977 |
Gefitinib (JP18/USAN/INN); Iressa (TN) |
(P) unclassified |
| D02008 |
Tadalafil (JAN/USP/INN); Adcirca (TN); Cialis (TN); Zalutia (TN) |
(CI,P) CYP inhibition: CYP3A4 |
| D02009 |
Erythromycin lactobionate (JP18/USP); Erythrocin (TN) |
(P) unclassified |
| D02045 |
Benidipine hydrochloride (JP18); KW 3049; Coniel (TN) |
(P) CYP inhibition: CYP3A4 |
| D02086 |
Lidocaine hydrochloride (JAN/USP); Dalcaine (TN); Xylocaine (TN) |
(P) CYP inhibition: CYP3A4 |
| D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP18); Aleviatin (TN); Dilantin (TN) |
(P) unclassified |
| D02114 |
Hydroxychloroquine sulfate (JAN/USP); Plaquenil (TN) |
(P) CYP inhibition: CYP3A4 |
| D02184 |
Erythromycin stearate (JP18/USP); Bristamycin (TN) |
(P) unclassified |
| D02214 |
Epirubicin hydrochloride (JP18/USP); EPI; Ellence (TN) |
(P) unclassified |
| D02219 |
Terbinafine hydrochloride (JP18/USP); Lamisil (TN) |
(P) CYP inhibition: CYP3A4 |
| D02229 |
Sildenafil citrate (JAN/USP); Revatio (TN); Viagra (TN) |
(P) CYP inhibition: CYP3A4 |
| D02260 |
Paroxetine hydrochloride hemihydrate (USP); Paroxetine hydrochloride hydrate (JP18); Paxil (TN) |
(P) CYP inhibition: CYP2D6 |
| D02372 |
Perospirone hydrochloride hydrate (JAN); Lullan (TN) |
(P) unclassified |
| D02409 |
Caffeine and sodium benzoate (JP18); Sodium caffeine benzoate; Annaca (TN) |
(P) unclassified |
| D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) unclassified |
| D02567 |
Escitalopram oxalate (JAN/USP); Lexapro (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D02574 |
Atomoxetine hydrochloride (JAN/USP); Tomoxetine hydrochloride; Strattera (TN) |
(P) CYP inhibition: CYP2D6 |
| D02587 |
Metildigoxin (JP18); Lanirapid (TN) |
(P) unclassified |
| D02624 |
Eszopiclone (JAN/USP/INN); Estorra (TN); Lunesta (TN) |
(P) CYP inhibition: CYP3A4 |
| D02689 |
Ramelteon (JAN/USAN/INN); Rozerem (TN) |
(P) unclassified |
| D02732 |
Pranlukast hydrate (JP18); Onon (TN) |
(P) CYP inhibition: CYP3A4 |
| D02968 |
Aprepitant (JAN/USP/INN); Aponvie (TN); Emend (TN); Cinvanti (TN) |
(P) CYP inhibition: CYP3A4 |
| D03150 |
Bortezomib (JAN/USAN/INN); Velcade (TN) |
(P) unclassified |
| D03218 |
Axitinib (JAN/USAN); Inlyta (TN) |
(P) CYP inhibition: CYP3A4 |
| D03260 |
Vardenafil hydrochloride hydrate (JAN); Vardenafil monohydrochloride trihydrate; Levitra (TN); Staxyn (TN) |
(CI,P) CYP inhibition: CYP3A4 |
| D03306 |
Calcium polycarbophil (USP); Polycarbophil calcium (JAN); Mitrolan (TN) |
(P) unclassified |
| D03658 |
Dasatinib (JAN/INN) |
(P) CYP inhibition: CYP3A4 |
| D03799 |
Dienogest (JAN/USAN/INN); Endometrion (TN) |
(P) CYP inhibition: CYP3A4 |
| D03820 |
Dutasteride (JAN/USP/INN); Avodart (TN) |
(P) CYP inhibition: CYP3A4 |
| D04023 |
Erlotinib hydrochloride (JAN/USAN); Tarceva (TN) |
(P) CYP inhibition: CYP3A4 |
| D04024 |
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) |
(P) CYP inhibition: CYP3A4 |
| D04148 |
Fenfluramine hydrochloride (JAN/USAN); Fintepla (TN); Pondimin (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D04340 |
Dextromethorphan hydrobromide and potassium cresolsulfonate; Medicon (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D04641 |
Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) |
(P) CYP inhibition: CYP3A4 |
| D04768 |
Lonafarnib (JAN/USAN/INN); Zokinvy (TN) |
(CI,P) unclassified |
| D04820 |
Lurasidone hydrochloride (JAN/USAN); SM 13496; Latuda (TN) |
(CI,P) CYP inhibition: CYP3A4 |
| D04905 |
Memantine hydrochloride (JAN/USP); Namenda (TN); Memary (TN) |
(P) unclassified |
| D05380 |
Pazopanib hydrochloride (JAN/USAN); Votrient (TN) |
(P) unclassified |
| D05429 |
Aminophylline hydrate (JP18) |
(P) unclassified |
| D05462 |
Oxycodone hydrochloride hydrate (JP18) |
(P) CYP inhibition: CYP3A4 |
| D06068 |
Temsirolimus (JAN/USAN/INN); Torisel (TN) |
(P) CYP inhibition: CYP3A4 |
| D06199 |
Trabectedin (JAN/USAN/INN); Yondelis (TN) |
(P) CYP inhibition: CYP3A4 |
| D06273 |
Imidafenacin (JAN/INN); Uritos (TN); Staybla (TN) |
(P) CYP inhibition: CYP3A4 |
| D06282 |
Varenicline tartrate (JAN/USAN); Chantix (TN); Champix (TN); Tyrvaya (TN) |
(P) unclassified |
| D06315 |
Fluticasone furoate (JAN/USAN/INN); Veramyst (TN) |
(P) CYP inhibition: CYP3A4 |
| D06402 |
Sunitinib malate (JAN/USAN); Sutent (TN) |
(P) CYP inhibition: CYP3A4 |
| D06405 |
Nalfurafine hydrochloride (JAN/USAN) |
(P) CYP inhibition: CYP3A4 |
| D06413 |
Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) |
(P) CYP inhibition: CYP3A4 |
| D06414 |
Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) |
(P) CYP inhibition: CYP3A4 |
| D06597 |
Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
(P) CYP inhibition: CYP3A4 |
| D06637 |
Romidepsin (JAN/USAN/INN); Istodax (TN) |
(P) unclassified |
| D07505 |
Latanoprost and timolol maleate; Xalacom (TN) |
(P) unclassified |
| D07569 |
Candesartan cilexetil and anmlodipine besylate (JP18); Unisia (TN) |
(P) CYP inhibition: CYP3A4 |
| D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) unclassified |
| D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) unclassified |
| D07869 |
Donepezil (JAN/INN); Donaz (TN); Allydone (TN) |
(P) CYP inhibition: CYP3A4 |
| D08095 |
Ivabradine hydrochloride (JAN/USAN); Ivabrandine hydrochloride; Corlanor (TN); Corlentor (TN); Coralan (TN) |
(P) CYP inhibition: CYP3A4 |
| D08488 |
Amlodipine besilate and atorvastatin calcium; Caduet (TN) |
(P) CYP inhibition: CYP3A4 |
| D08493 |
Dorzolamide hydrochloride and timolol maleate (JP18); Cosopt (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D08497 |
Rupatadine fumarate (JAN); Rinialer (TN); Rupafin (TN) |
(P) CYP inhibition: CYP3A4 |
| D08575 |
Tetrabenazine (JAN/INN); Nitoman (TN); Xenazine (TN) |
(P) CYP inhibition: CYP2D6 |
| D08699 |
Salmeterol xinafoate and fluticasone propionate; Adoair diskus (TN); Aerivio Spiromax (TN) |
(P) CYP inhibition: CYP3A4 |
| D08856 |
Anamorelin hydrochloride (JAN/USAN); Adlumiz (TN) |
(P) CYP inhibition: CYP3A4 |
| D08923 |
Fesoterodine fumarate (JAN/USAN); Toviaz (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D08976 |
Pomalidomide (JAN/USAN/INN); Pomalyst (TN) |
(P) CYP inhibition: CYP3A4 |
| D09017 |
Ticagrelor (JAN/USAN/INN); Brilinta (TN) |
(CI,P) unclassified |
| D09033 |
Voclosporin (JAN/USAN/INN); Lupkynis (TN) |
(CI,P) CYP inhibition: CYP3A4 |
| D09319 |
Indacaterol maleate (JAN/USAN); Arcapta neohaler (TN) |
(P) CYP inhibition: CYP3A4 |
| D09348 |
Fostamatinib disodium (USAN); Fostamatinib sodium hydrate (JAN); Fostamatinib disodium hexahydrate; Tavalisse (TN) |
(P) CYP inhibition: CYP3A4 |
| D09572 |
Riociguat (JAN/USAN/INN); Adempas (TN) |
(P) unclassified |
| D09587 |
Brentuximab vedotin (USAN/INN); Brentuximab vedotin (genetical recombination) (JAN); Adcetris (TN) |
(P) unclassified |
| D09594 |
Olmesartan medoxomil and azelnidipine; Rezaltas (TN) |
(P) CYP inhibition: CYP3A4 |
| D09595 |
Budesonide and formoterol fumarate dihydrate; Symbicort (TN); Budeforu (TN) |
(P) CYP inhibition: CYP3A4 |
| D09638 |
Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) |
(CI,P) CYP inhibition: CYP3A4 |
| D09728 |
Bosutinib hydrate (JAN); Bosutinib monohydrate; Bosulif (TN) |
(P) CYP inhibition: CYP3A4 |
| D09730 |
Olaparib (JAN/USAN/INN); Lynparza (TN) |
(P) unclassified |
| D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(P) CYP inhibition: CYP3A4 |
| D09743 |
Telmisartan and amlodipine besilate (JP18); Telmisartan and amlodipine besylate; Micamlo (TN); Twynsta (TN) |
(P) CYP inhibition: CYP3A4 |
| D09744 |
Pioglitazone hydrochloride and metformin hydrochloride (JP18); Pioglitazone and metformin; Metact (TN) |
(P) unclassified |
| D09745 |
Valsartan and amlodipine besilate; Exforge (TN) |
(P) CYP inhibition: CYP3A4 |
| D09753 |
Saxagliptin hydrate (JAN); Onglyza (TN) |
(P) CYP inhibition: CYP3A4 |
| D09783 |
Tofacitinib citrate (JAN/USAN); Tasocitinib citrate; Xeljanz (TN) |
(P) CYP inhibition: CYP3A4 |
| D09815 |
Travoprost and timolol maleate; Duotrav (TN) |
(P) unclassified |
| D09894 |
Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) |
(CI,P) CYP inhibition: CYP2D6 |
| D09951 |
Ponatinib hydrochloride (JAN/USAN); Iclusig (TN) |
(P) unclassified |
| D09956 |
Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN); Vanflyta (TN) |
(P) unclassified |
| D09958 |
Rilpivirine hydrochloride (JAN/USAN); Edurant (TN) |
(P) unclassified |
| D09960 |
Ruxolitinib phosphate (JAN/USAN); Jakafi (TN); Jakavi (TN); Opzelura (TN) |
(P) CYP inhibition: CYP3A4 |
| D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) unclassified |
| D10024 |
Selumetinib sulfate (JAN/USAN); Koselugo (TN) |
(P) CYP inhibition: CYP3A4 |
| D10082 |
Suvorexant (JAN/USAN); MK-4305; Belsomra (TN) |
(P) unclassified |
| D10095 |
Cabozantinib s-malate (USAN); Cabozantinib malate (JAN); Cometriq (TN); Cabometyx (TN) |
(P) unclassified |
| D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(P) CYP inhibition: CYP3A4 |
| D10135 |
Macitentan (JAN/USAN); Opsumit (TN) |
(P) CYP inhibition: CYP3A4 |
| D10137 |
Regorafenib hydrate (JAN); Stivarga (TN) |
(P) CYP inhibition: CYP3A4 |
| D10185 |
Vortioxetine hydrobromide (JAN/USAN); Brintellix (TN); Trintellix (TN) |
(P) CYP inhibition: CYP2D6 |
| D10223 |
Ibrutinib (JAN/USAN); Imbruvica (TN) |
(P) unclassified |
| D10243 |
Irbesartan and amlodipine besilate (JP18); Aimix (TN) |
(P) CYP inhibition: CYP3A4 |
| D10253 |
Alogliptin benzoate and metformin hydrochloride; Kazano (TN); Vipdomet (TN) |
(P) unclassified |
| D10298 |
Brimonidine tartrate and timolol maleate; Combigan (TN); Aibeta (TN) |
(P) unclassified |
| D10309 |
Brexpiprazole (JAN/USAN/INN); Rexulti (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(P) unclassified |
| D10450 |
Alectinib hydrochloride (JAN); Alecensa (TN) |
(P) CYP inhibition: CYP3A4 |
| D10452 |
Cabazitaxel acetonate (JAN); Cabazitaxel acetone; Jevtana (TN) |
(P) unclassified |
| D10466 |
Vonoprazan fumarate (JAN/USAN); Takecab (TN); Voquezna (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D10478 |
Naldemedine tosylate (JAN/USAN); Naldemedine tosilate; Symproic (TN) |
(P) CYP inhibition: CYP3A4 |
| D10501 |
Fluticasone furoate and vilanterol trifenatate; Breo ellipta (TN); Relvar ellipita (TN) |
(P) CYP inhibition: CYP3A4 |
| D10505 |
Glycopyrronium bromide and indacaterol maleate; Ultibro (TN) |
(P) CYP inhibition: CYP3A4 |
| D10506 |
Fluticasone propionate and formoterol fumarate hydrate; Flutiform (TN) |
(P) CYP inhibition: CYP3A4 |
| D10512 |
Brinzolamide and timolol maleate; Azorga (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D10516 |
Aripiprazole hydrate (JAN); Aripiprazole monohydrate; Abilify maintena (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D10518 |
Valaciclovir hydrochloride hydrate (JAN); Valacyclovir hydrochloride hydrate; Valaciclovir (TN) |
(P) unclassified |
| D10524 |
Azilsartan and amlodipine besilate; Zacras (TN) |
(P) CYP inhibition: CYP3A4 |
| D10525 |
Valsartan and cilnidipine; Atedio (TN) |
(P) CYP inhibition: CYP3A4 |
| D10533 |
Umeclidinium bromide and vilanterol; Anoro (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(P) unclassified |
| D10564 |
Amenamevir (JAN/INN); Amenalief (TN) |
(P) unclassified |
| D10569 |
Tafluprost and timolol maleate; Tapcom (TN) |
(P) unclassified |
| D10578 |
Ledipasvir and sofosbuvir; Harvoni (TN) |
(P) unclassified |
| D10633 |
Finerenone (JAN/USAN/INN); Kerendia (TN) |
(P) CYP inhibition: CYP3A4 |
| D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(P) unclassified |
| D10679 |
Venetoclax (JAN/USAN/INN); Venclexta (TN) |
(CI,P) unclassified |
| D10688 |
Abemaciclib (JAN/USAN/INN); Verzenio (TN) |
(P) unclassified |
| D10743 |
Vildagliptin and metformin hydrochloride |
(P) unclassified |
| D10761 |
Polatuzumab vedotin (USAN); Polatuzumab vedotin (genetical recombination) (JAN); Polatuzumab vedotin-piiq; Polivy (TN) |
(P) unclassified |
| D10774 |
Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D10775 |
Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D10780 |
Perampanel hydrate (JAN); Fycompa (TN) |
(P) unclassified |
| D10790 |
Mirogabalin besylate (USAN); Mirogabalin besilate (JAN) |
(P) unclassified |
| D10800 |
Gilteritinib fumarate (JAN/USAN); Xospata (TN) |
(P) CYP inhibition: CYP3A4 |
| D10805 |
Telmisartan, amlodipine and hydrochlorothiazide; Micatrio (TN) |
(P) CYP inhibition: CYP3A4 |
| D10827 |
Sofosbuvir and velpatasvir; Epclusa (TN) |
(P) CYP inhibition: CYP3A4 |
| D10836 |
Emtricitabine, rilpivirine and tenofovir alafenamide; Odefsey (TN) |
(P) unclassified |
| D10866 |
Brigatinib (JAN/USAN); Alunbrig (TN) |
(P) CYP inhibition: CYP3A4 |
| D10891 |
Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN); Tabrecta (TN) |
(P) CYP inhibition: CYP3A4 |
| D10892 |
Esaxerenone (JAN/INN) |
(P) unclassified |
| D10893 |
Acalabrutinib (JAN/USAN/INN); Calquence (TN) |
(P) unclassified |
| D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(P) CYP inhibition: CYP3A4 |
| D10927 |
Erdafitinib (JAN/USAN/INN); Balversa (TN) |
(P) CYP inhibition: CYP3A4 |
| D10993 |
Tucidinostat (JAN/USAN/INN); Hiyasta (TN) |
(P) unclassified |
| D10999 |
Valbenazine tosylate (USAN); Valbenazine tosilate (JAN); Valbenazine ditosylate; Ingrezza (TN); Dysval (TN) |
(P) CYP inhibition: CYP3A4 |
| D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(P) unclassified |
| D11022 |
Lemborexant (JAN/USAN/INN); Dayvigo (TN) |
(P) CYP inhibition: CYP3A4 |
| D11035 |
Fluticasone furoate, umeclidinium bromide and vilanterol; Trelegy ellipta (TN) |
(P) unclassified |
| D11040 |
Apalutamide (JAN/INN); Erleada (TN) |
(P) CYP inhibition: CYP3A4 |
| D11048 |
Upadacitinib hydrate (JAN); Upadacitinib hemihydrate; Rinvoq (TN) |
(P) CYP inhibition: CYP3A4 |
| D11053 |
Encorafenib (JAN/USAN/INN); Braftovi (TN) |
(P) CYP inhibition: CYP3A4 |
| D11070 |
Tirabrutinib hydrochloride (JAN/USAN); Velexbru (TN) |
(P) unclassified |
| D11090 |
Ivosidenib (JAN/USAN/INN); Tibsovo (TN) |
(P) unclassified |
| D11093 |
Avacopan (JAN/USAN/INN); Tavneos (TN) |
(P) CYP inhibition: CYP3A4 |
| D11109 |
Anagliptin and Metformin hydrochloride |
(P) unclassified |
| D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(P) unclassified |
| D11282 |
Dolutegravir sodium and rilpivirine hydrochloride; Juluca (TN) |
(P) unclassified |
| D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
| D11371 |
Capivasertib (JAN/USAN); Truqap (TN) |
(P) CYP inhibition: CYP3A4 |
| D11417 |
Pemigatinib (JAN/USAN/INN); Pemazyre (TN) |
(P) CYP inhibition: CYP3A4 |
| D11422 |
Zanubrutinib (JAN/USAN/INN); Brukinsa (TN) |
(P) unclassified |
| D11454 |
Repotrectinib (JAN/USAN); Augtyro (TN) |
(P) CYP inhibition: CYP3A4 |
| D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(P) unclassified |
| D11525 |
Enfortumab vedotin (USAN); Enfortumab vedotin (genetical recombination) (JAN); Enfortumab vedotin-ejfv; Padcev (TN) |
(P) unclassified |
| D11584 |
Budesonide, glycopyrronium bromide and formoterol fumarate; Budesonide, glycopyrrolate and formoterol fumarate; Breztri (TN) |
(P) unclassified |
| D11659 |
Tolvaptan sodium phosphate (JAN); Samtasu (TN) |
(P) unclassified |
| D11662 |
Valemetostat tosilate (JAN); Valemetostat tosylate; Ezharmia (TN) |
(P) unclassified |
| D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(P) CYP inhibition: CYP3A4 |
| D11725 |
Futibatinib (JAN/USAN/INN); Lytgobi (TN) |
(P) unclassified |
| D11804 |
Aspirin and vonoprazan; Cabpirin (TN) |
(P) unclassified |
| D11814 |
Tisotumab vedotin (USAN/INN); Tisotumab vedotin (genetical recombination) (JAN); Tisotumab vedotin-tftv; Tivdak (TN) |
(P) unclassified |
| D11861 |
Indacaterol acetate, glycopyrronium bromide and mometasone furoate; Enerzair (TN) |
(P) unclassified |
| D11862 |
Indacaterol and mometasone furoate; Atectura (TN) |
(P) unclassified |
| D11887 |
Daridorexant hydrochloride (JAN/USAN); Quviviq (TN) |
(P) unclassified |
| D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(P) unclassified |
| D12245 |
Lazertinib mesylate (USAN); Lazertinib mesilate hydrate (JAN); Lazcluze (TN) |
(P) CYP inhibition: CYP3A4 |
| D12265 |
Mavacamten (JAN/USAN/INN); Camzyos (TN) |
(P) unclassified |
| D12311 |
Bortezomib hydrate (JAN) |
(P) unclassified |
| D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(P) unclassified |
| D12963 |
Macitentan and tadalafil; Opsynvi (TN); Yuvanci (TN) |
(CI,P) unclassified |
